Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06227728

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Led by Gene Solutions · Updated on 2026-01-16

50

Participants Needed

2

Research Sites

144 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is an observational clinical trial, aiming to investigate whether the ctDNA dynamics could predict early response to ICIs in patients with advanced-stage cancer. Moreover, conventional tumor markers PD-L1, TMB and MSI are to be investigated for their combined prognostic values in ICI treatment.

CONDITIONS

Official Title

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years and older, both genders.
  • Diagnosed with stage IV cancer (lung, colorectal, breast, liver, gastric, etc.) and indicated for immune checkpoint inhibitor (ICI) treatment, either first or second line.
  • Concurrent chemotherapy with ICI is allowed.
  • Formalin-fixed paraffin-embedded (FFPE) or fine needle aspiration (FNA) tumor sample is available.
  • Compliant with the treatment protocol.
  • Provided consent to participate in the study.
Not Eligible

You will not qualify if you...

  • Already started immune checkpoint inhibitor (ICI) treatment before enrollment.
  • Receiving consolidation ICI therapy (e.g., Durvalumab).
  • Already started chemotherapy before enrollment.
  • Medical or psychiatric conditions or occupational responsibilities that may prevent compliance with the protocol.
  • Did not agree to participate in the study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Medicine and Pharmacy at HCMC

Ho Chi Minh City, Hồ Chí Minh, Vietnam

Actively Recruiting

2

Medical Genetics Institute

Ho Chi Minh City, Vietnam

Not Yet Recruiting

Loading map...

Research Team

L

Lan NL Tu, PHD

CONTACT

V

VAN T Phan, MSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here